Correlation Between Smoking Status and Respiratory Health Among Healthcare Workers in Hospitals of Mosul City/Iraq
Korelasi Antara Status Merokok dan Kesehatan Pernapasan di Kalangan Pekerja Kesehatan Pekerja di Rumah Sakit di Kota Mosul/Irak
DOI:
https://doi.org/10.21070/ijhsm.v1i2.39Keywords:
Smoking, Hookah, Narghile, Lung function, FEV1, FVC, FEV1/FVC%, respiratory diseases, Healthcare workers, HospitalsAbstract
This paper examines the effects of smoking on respiratory health in healthcare workers in the city of Mosul, Iraq. This was carried out in two main hospitals: Ibn Sina and Al-Salam Teaching Hospitals. A total sample of 162 participants was taken into consideration. The information obtained was through questionnaires interviews and tests of lung function, which included FVC, FEV1, and FEV1/FVC ratio. In this regard, it can be noticed that the percent distribution was: current smokers consisted of 30.9%, ex-smokers 4.3%, and nonsmokers, 64.8%. The research indicates that smoking is closely linked with asthma, bronchitis, and COVID-19. This finding reiterates the key that both smoking cessation programs targeting the smoker and improved chronic obstructive pulmonary disease control among healthcare employees are of immense importance.
الْخُلَاصَةُ
تَبْحَث هَذِهِ الْوَرَقَةِ فِي اثَارِ التَّدْخِين عَلَى صِحَّةِ الْجِهَازِ التَّنَفُّسِيِّ لَدَى الْعَامِلِينَ فِي مَجَالِ الرِّعَايَةِ الصِّحِّيَّةِ فِي مَدِينَةٍ الْمَوْصِل ، الْعِرَاق. تَمّ تَنْفِيذُ ذَلِكَ فِي مُسْتَشْفَىين رُئِيَسِيِّين: مُسْتَشْفَى ابْنُ سِينَا وَمُسْتَشْفَى السَّلَامُ التَّعْلِيمِيّ.
تَمَّ أَخَذَ عَيْنَهُ إجْمَالِيَّة مِنْ 162 مُشَارِكًا فِي الِاعْتِبَارِ. وَكَانَتْ الْمَعْلُومَاتِ الَّتِي تَمَّ الْحُصُولِ عَلَيْهَا مِنْ خِلَالِ الِاسْتِبْيَانَات وَالْمَقَابَلَات وَاخْتِبَارَات وَظَائِفِ الرِّئَة ، وَاَلَّتِي شَمِلَتْ FVC, FEV1, وَفِي هَذَا الصَّدَدِ ، يُمْكِن مُلَاحَظَةِ أَنَّ النِّسْبَةَ الْمِئَوِيَّة لِلتَّوْزِيع كَانَتْ: الْمُدَخِّنِون الْحَالَيْون يُتَأَلَّفُونَ مِنْ 30.9 ٪ ، وَالْمَدْخُنون السَّابِقُونَ 4.3 ٪ ، وَغَيْر المُدَخِّنِين 64.8٪.
تَظْهَرُ هَذِهِ الدِّرَاسَةِ أَنَّ هُنَاكَ عَلَاقَة كَبِيرَةٌ بَيْنَ حَالَةِ التَّدْخِين وَأَمْرَاض الْجِهَازِ التَّنَفُّسِيِّ مِثْل الرَّبْو وَالْتِهَاب الشُّعَبِ الْهَوَائِيَّةِ وَكَوْفيد 19. مَرَّةً أُخْرَى ، يُؤَكِّدُ هَذَا عَلَى أَنَّ بَرَامِج الْإِقْلَاعُ عَنْ التَّدْخِين الْمُسْتَهْدفه وَالتَّدْخِلات الصِّحِّيَّة التَّنَفُّسِيَّة المُحْسِنَة بَيْنَ الْعَامِلَيْنِ فِي مَجَالِ الرِّعَايَةِ الصِّحِّيَّةِ يَجِبُ أَنْ تَكُونَ مَسْأَلَةُ مُلِحَّة.
Highlights:
- Smoking affects healthcare workers’ respiratory health in Mosul hospitals.
- Study links smoking to asthma, bronchitis, COVID-19, and COPD risks.
- Urges smoking cessation programs and improved respiratory care for healthcare staff.
Keywords: Smoking, Hookah, Narghile, Lung function, FEV1, FVC, FEV1/FVC%, respiratory diseases, Healthcare workers, Hospitals
References
N. Muwfaq Younis and A. K. M. Taher, “Efficacy of Trans Theoretical Model Intervention for Improving Behaviors related to Electronic Hookah Smoking among Healthcare Workers in Mosul Hospital: A Randomized Control Trail,” 2023.
A. Khalil, R. Dhingra, J. Al-Mulki, M. Hassoun, and N. Alexis, “Questioning the sex-specific differences in the association of smoking on the survival rate of hospitalized COVID-19 patients,” PLoS One, vol. 16, no. 8 August, Aug. 2021, doi: 10.1371/journal.pone.0255692.
Y. Helexandra, Y. S. Sabri, and F. Anggrainy, “Relationship Between Smoking Status and Smoking Index Against COVID-19 Disease Course in Treated Patients at Dr. M Djamil General Hospital, Padang,” Respiratory Science, vol. 3, no. 1, pp. 51–66, Sep. 2022, doi: 10.36497/respirsci.v3i1.58.
L. Josephs, D. Culliford, M. Johnson, and M. Thomas, “Improved outcomes in ex-smokers with COPD: A UK primary care observational cohort study,” European Respiratory Journal, vol. 49, no. 5, May 2017, doi: 10.1183/13993003.02114-2016.
C. S. H. Ho, E. L. Y. Tan, R. C. M. Ho, and M. Y. L. Chiu, “Relationship of anxiety and depression with respiratory symptoms: Comparison between depressed and non-depressed smokers in singapore,” Int J Environ Res Public Health, vol. 16, no. 1, Jan. 2019, doi: 10.3390/ijerph16010163.
L. Han et al., “Smoking and Influenza-associated Morbidity and Mortality: A Systematic Review and Meta-analysis,” May 01, 2019, Lippincott Williams and Wilkins. doi: 10.1097/EDE.0000000000000984.
D. Simons, O. Perski, L. Shahab, J. Brown, and R. Bailey, “Association of smoking status with hospitalisation for COVID-19 compared with other respiratory viruses a year previous: a case-control study at a single UK National Health Service trust,” F1000Res, vol. 10, p. 846, Aug. 2021, doi: 10.12688/f1000research.55502.1.
A. L. Merianos, R. A. Jandarov, and E. M. Mahabee-Gittens, “Tobacco Smoke Exposure, Respiratory Health, and Health-care Utilization Among US Adolescents,” Chest, vol. 158, no. 3, pp. 1104–1114, Sep. 2020, doi: 10.1016/j.chest.2020.03.038.
K. Nishimura, T. Oga, K. Nakayasu, M. Ogasawara, Y. Hasegawa, and S. Mitsuma, “How different are COPD-specific patient reported outcomes, health status, dyspnoea and respiratory symptoms? An observational study in a working population,” BMJ Open, vol. 9, no. 7, p. e025132, Jul. 2019, doi: 10.1136/bmjopen-2018-025132.
M. B. A. Bashir et al., “Interaction of smoking and social status on the risk of respiratory outcomes in a Swedish adult population: A Nordic Epilung study,” Respir Med, vol. 211, May 2023, doi: 10.1016/j.rmed.2023.107192.
D. Mackay, S. Haw, J. G. Ayres, C. Fischbacher, and J. P. Pell, “Smoke-free Legislation and Hospitalizations for Childhood Asthma A bs tr ac t,” 2010. [Online]. Available: www.scotland.gov.uk/Resource/
A. R. Panzer et al., “Lung microbiota is related to smoking status and to development of acute respiratory distress syndrome in critically Ill trauma patients,” Am J Respir Crit Care Med, vol. 197, no. 5, pp. 621–631, Mar. 2018, doi: 10.1164/rccm.201702-0441OC.
C. L. Le Guen, K. C. Muir, M. Simons, D. L. Coffman, and R. S. Soans, “The Impact of Smoking Status and Smoking-Related Comorbidities on Coronavirus Disease 2019 Patient Outcomes: A Causal Mediation Analysis,” Nicotine and Tobacco Research, vol. 25, no. 2, pp. 331–338, Feb. 2023, doi: 10.1093/ntr/ntac193.
D. Puebla Neira, A. Watts, J. Seashore, E. Polychronopoulou, Y. F. Kuo, and G. Sharma, “Smoking and risk of COVID-19 hospitalization,” Respir Med, vol. 182, Jun. 2021, doi: 10.1016/j.rmed.2021.106414.
L. A. Burke et al., “Associations in Cigarette Smoking and Health Conditions by Race/Ethnicity Among a Diverse Sample of Patients Receiving Treatment in a Federally Qualified Health Care Setting in Chicago,” Health Equity, vol. 7, no. 1, pp. 80–88, Feb. 2023, doi: 10.1089/heq.2022.0056.
A. M. Erzurumluoglu et al., “Meta-analysis of up to 622,409 individuals identifies 40 novel smoking behaviour associated genetic loci,” Mol Psychiatry, vol. 25, no. 10, pp. 2392–2409, Oct. 2020, doi: 10.1038/s41380-018-0313-0.
A. Saracen, “Cigarette smoking and respiratory system diseases in adolescents,” Adv Exp Med Biol, vol. 944, pp. 81–85, Nov. 2017, doi: 10.1007/5584_2016_60.
N. A. Madani and D. O. Carpenter, “Patterns of Emergency Room Visits for Respiratory Diseases in New York State in Relation to Air Pollution, Poverty and Smoking,” Int J Environ Res Public Health, vol. 20, no. 4, Feb. 2023, doi: 10.3390/ijerph20043267.
E. J. Grundy, T. Suddek, F. T. Filippidis, A. Majeed, and S. Coronini-Cronberg, “Smoking, SARS-CoV-2 and COVID-19: A review of reviews considering implications for public health policy and practice,” Jul. 01, 2020, International Society for the Prevention of Tobacco Induced Diseases. doi: 10.18332/TID/124788.
Q. Song, P. Chen, and X. M. Liu, “The role of cigarette smoke-induced pulmonary vascular endothelial cell apoptosis in COPD,” Dec. 01, 2021, BioMed Central Ltd. doi: 10.1186/s12931-021-01630-1.
R. A. B. Nucci et al., “Cigarette smoking impairs the diaphragm muscle structure of patients without respiratory pathologies: An autopsy study,” Cellular Physiology and Biochemistry, vol. 53, no. 4, pp. 648–655, 2019, doi: 10.33594/000000163.
A. Israel, E. Feldhamer, B. Amnon Lahad, M. Diane Levin-Zamir, M. Gil Lavie, and M. Authors Affiliations, “Smoking and the risk of COVID-19 in a large observational population study”, doi: 10.1101/2020.06.01.20118877.
A. Grzywa-Celińska, A. Krusiński, and J. Milanowski, “‘Smoging kills’ – Effects of air pollution on human respiratory system,” 2020, Institute of Agricultural Medicine. doi: 10.26444/aaem/110477.
L. Hedman et al., “Receiving support to quit smoking and quit attempts among smokers with and without smoking related diseases: Findings from the EUREST-PLUS ITC Europe Surveys,” 2018, International Society for the Prevention of Tobacco Induced Diseases. doi: 10.18332/tid/102787.
C. Jiang, Q. Chen, and M. Xie, “Smoking increases the risk of infectious diseases: A narrative review,” Jul. 01, 2020, European Publishing. doi: 10.18332/tid/123845.
V. Cristina, A. I. Raluca, T. C. Antigona, O. Melinte, and A. T. Cernomaz, “Why making smoking cessation a priority for rare interstitial lung disease smokers?,” Tob Prev Cessat, vol. 10, no. June, pp. 1–10, Jun. 2024, doi: 10.18332/tpc/190591.
R. Magleby et al., “Impact of Severe Acute Respiratory Syndrome Coronavirus 2 Viral Load on Risk of Intubation and Mortality among Hospitalized Patients with Coronavirus Disease 2019,” Clinical Infectious Diseases, vol. 73, no. 11, pp. E4197–E4205, Dec. 2021, doi: 10.1093/cid/ciaa851.
M. Mabani, N. Seddighi, E. Yadegarifard, A. Salimi Asl, and hesam Alizade, “Association Between Tobacco Use and COVID-19: A Narrative Review,” Tobacco and Health, vol. 1, no. 1, pp. 44–51, Jan. 2022, doi: 10.34172/thj.2022.07.
K. J. Li et al., “Dysbiosis of lower respiratory tract microbiome are associated with inflammation and microbial function variety,” Respir Res, vol. 20, no. 1, Dec. 2019, doi: 10.1186/s12931-019-1246-0.
H. Sharifi et al., “Burden of obstructive lung disease in Iran: Prevalence and risk factors for COPD in North of Iran,” Int J Prev Med, vol. 11, no. 1, Jan. 2020, doi: 10.4103/ijpvm.IJPVM_478_18.
K. De Troeyer et al., “Identifying cleaning products associated with short-term work-related respiratory symptoms: A workforce-based study in domestic cleaners,” Environ Int, vol. 162, Apr. 2022, doi: 10.1016/j.envint.2022.107170.
S. Siddiqui, M. Amir, T. Aggarwal, B. Sharma, and S. Agarwal, “Quantitative assessment of cardiovascular risks in cigarette smokers using pack-years of smoking,” Natl J Physiol Pharm Pharmacol, no. 0, p. 1, 2019, doi: 10.5455/njppp.2019.9.0101605022019.
J. J. K. Jaakkola, S. Hernberg, T. K. Lajunen, P. Sripaijboonkij, L. P. Malmberg, and M. S. Jaakkola, “Smoking and lung function among adults with newly onset asthma,” BMJ Open Respir Res, vol. 6, no. 1, Mar. 2019, doi: 10.1136/bmjresp-2018-000377.
A. E. Sprio et al., “The influence of smoking on asthma in the real-life,” Respir Med, vol. 170, Aug. 2020, doi: 10.1016/j.rmed.2020.106066.
A. Tajlil, S. Ghaffari, L. Pourafkari, S. Mashayekhi, and N. Roshanravan, “Nicotine and smoking in the COVID-19 era,” J Cardiovasc Thorac Res, vol. 12, no. 2, pp. 136–139, 2020, doi: 10.34172/jcvtr.2020.22.
S. Asfaw, F. Enquselassie, Y. Tefera, M. Gizaw, S. Wakuma, and M. Woldemariam, “Determinants of Chronic Respiratory Symptoms among Pharmaceutical Factory Workers,” J Trop Med, vol. 2018, 2018, doi: 10.1155/2018/3815689.
R. Ng, R. Sutradhar, Z. Yao, W. P. Wodchis, and L. C. Rosella, “Smoking, drinking, diet and physical activity - Modifiable lifestyle risk factors and their associations with age to first chronic disease,” Int J Epidemiol, vol. 49, no. 1, pp. 113–130, Feb. 2020, doi: 10.1093/ije/dyz078.
D. Baliunas et al., “Incidence of chronic disease following smoking cessation treatment: A matched cohort study using linked administrative healthcare data in Ontario, Canada,” PLoS One, vol. 18, no. 7 July, Jul. 2023, doi: 10.1371/journal.pone.0288759.
